OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
RDOR359

Rede D'Or Sao Luiz SA

Healthcare Facilities & ServicesVerified

Rede D'Or Sao Luiz SA has a debt-to-equity ratio of 2.58, indicating a significant reliance on debt financing, which is higher than the typical industry median for healthcare facilities. The company's liquidity position is characterized by a current ratio of 2.79, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's free cash flow is negative at -3.17 billion BRL, which may limit its ability to fund operations and growth without additional financing. The company's profitability is reflected in a return on equity (ROE) of 24.23% and a return on assets (ROA) of 4.4%, which are key metrics for assessing the efficiency of capital use and asset management. These figures suggest that the company is generating a strong return for its shareholders relative to its equity base, but a moderate return on its total assets. The operating income of 9.89 billion BRL and net income of 4.69 billion BRL indicate a healthy profit margin, although the gross profit of 12.18 billion BRL suggests that the company is managing its direct costs effectively. Rede D'Or Sao Luiz SA's revenue is concentrated in the healthcare services segment, with no disclosed geographic diversification. The company's operations are primarily in Brazil, and there is no indication of significant international exposure. This concentration may expose the company to regional economic and regulatory risks, which could affect its revenue stability and growth potential. The company's growth trajectory is expected to be positive, with a mean price target of 49.02 BRL and a median price target of 51.00 BRL from analysts. The mean recommendation of 1.90, with 2 strong-buy and 7 buy ratings, indicates a generally optimistic outlook. However, the company's capital expenditure of -3.29 billion BRL and negative free cash flow suggest that it may need to seek additional financing to support its growth initiatives. The risk assessment for Rede D'Or Sao Luiz SA highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after accounting for total debt, which could impact its financial flexibility. The low dilution risk suggests that the company is not expected to issue a significant number of new shares in the near term, which is favorable for existing shareholders. Recent events and filings do not indicate any major operational or financial disruptions for Rede D'Or Sao Luiz SA. The company's financial performance and analyst ratings suggest a stable and growing business, but the negative free cash flow and high debt levels warrant close monitoring of its financial strategy and capital structure.

30-day price · RDOR3-5.53 (-13.8%)
Low$33.53High$40.84Close$34.47As of28 May, 00:00 UTC
Profile
CompanyRede D'Or Sao Luiz SA
TickerRDOR3.SA
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Rede D'Or Sao Luiz SA operates in the healthcare sector, providing medical services and facilities, and generates revenue primarily through patient care and related healthcare services.

Classification. Rede D'Or Sao Luiz SA is classified under the Healthcare Facilities & Services industry within the Healthcare Services & Equipment business sector, with a classification confidence of 0.92.

Rede D'Or Sao Luiz SA has a debt-to-equity ratio of 2.58, indicating a significant reliance on debt financing, which is higher than the typical industry median for healthcare facilities. The company's liquidity position is characterized by a current ratio of 2.79, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's free cash flow is negative at -3.17 billion BRL, which may limit its ability to fund operations and growth without additional financing. The company's profitability is reflected in a return on equity (ROE) of 24.23% and a return on assets (ROA) of 4.4%, which are key metrics for assessing the efficiency of capital use and asset management. These figures suggest that the company is generating a strong return for its shareholders relative to its equity base, but a moderate return on its total assets. The operating income of 9.89 billion BRL and net income of 4.69 billion BRL indicate a healthy profit margin, although the gross profit of 12.18 billion BRL suggests that the company is managing its direct costs effectively. Rede D'Or Sao Luiz SA's revenue is concentrated in the healthcare services segment, with no disclosed geographic diversification. The company's operations are primarily in Brazil, and there is no indication of significant international exposure. This concentration may expose the company to regional economic and regulatory risks, which could affect its revenue stability and growth potential. The company's growth trajectory is expected to be positive, with a mean price target of 49.02 BRL and a median price target of 51.00 BRL from analysts. The mean recommendation of 1.90, with 2 strong-buy and 7 buy ratings, indicates a generally optimistic outlook. However, the company's capital expenditure of -3.29 billion BRL and negative free cash flow suggest that it may need to seek additional financing to support its growth initiatives. The risk assessment for Rede D'Or Sao Luiz SA highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after accounting for total debt, which could impact its financial flexibility. The low dilution risk suggests that the company is not expected to issue a significant number of new shares in the near term, which is favorable for existing shareholders. Recent events and filings do not indicate any major operational or financial disruptions for Rede D'Or Sao Luiz SA. The company's financial performance and analyst ratings suggest a stable and growing business, but the negative free cash flow and high debt levels warrant close monitoring of its financial strategy and capital structure.
Key takeaways
  • Rede D'Or Sao Luiz SA has a strong return on equity (24.23%) but a moderate return on assets (4.4%), indicating efficient use of equity but less efficient use of total assets.
  • The company's debt-to-equity ratio of 2.58 suggests a high reliance on debt financing, which could increase financial risk.
  • Analysts have a generally positive outlook, with a mean price target of 49.02 BRL and a median price target of 51.00 BRL.
  • The company's negative free cash flow (-3.17 billion BRL) and significant capital expenditure (-3.29 billion BRL) may require additional financing to support growth.
  • The company's operations are concentrated in Brazil, which may expose it to regional economic and regulatory risks.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyBRL
Revenue$55.73B
Gross profit$12.18B
Operating income$9.89B
Net income$4.69B
R&D
SG&A
D&A
SBC
Operating cash flow$538.4M
CapEx-$3.29B
Free cash flow-$3.17B
Total assets$106.55B
Total liabilities$87.20B
Total equity$19.35B
Cash & equivalents$3.64B
Long-term debt$49.96B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$19.35B
Net cash-$46.32B
Current ratio2.8
Debt/Equity2.6
ROA4.4%
ROE24.2%
Cash conversion11.0%
CapEx/Revenue-5.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Biotechnology · cohort 117 companies
MetricRDOR3Activity
Op margin17.7%5.6% medp25 -4.2% · p75 12.6%top quartile
Net margin8.4%2.8% medp25 -3.4% · p75 8.8%above median
Gross margin21.9%36.5% medp25 23.7% · p75 65.2%bottom quartile
CapEx / revenue-5.9%-4.9% medp25 -11.5% · p75 -2.0%below median
Debt / equity258.0%69.3% medp25 7.9% · p75 120.9%top quartile
Observations
IR observations
Mean price target49.02 BRL
Median price target51.00 BRL
High price target56.00 BRL
Low price target37.70 BRL
Mean recommendation1.90 (1=strong buy, 5=strong sell)
Strong-buy count2.00
Buy count7.00
Hold count1.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate2.28 BRL
Last actual EPS2.12 BRL
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-23 02:36 UTC#1ee759c3
Market quoteclose BRL 34.07 · shares 2.21B diluted
no public URL
2026-05-23 02:37 UTC#9eefedc3
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 04:18 UTCJob: b7268d5a